Published Paper Details:

Genetic testing is a vital tool in assessing breast cancer risk, guiding treatment decisions, and improving early detection and personalized treatment. However, in India, limited genetic literacy--defined as the ability to understand and apply genetic information in healthcare decisions--combined with financial, infrastructural, and policy-related barriers, significantly restricts access to these life-saving services. Our findings show that only 10-15% of eligible patients undergo testing, and fewer than 30% of hospitals offer genetic counseling. Despite 22.5% of patients having a family history of breast cancer, awareness of BRCA mutations remains low. To improve access, we recommend integrating genetic counseling, expanding literacy programs, and implementing cost-reduction policies, ensuring early detection and personalized treatment for better patient outcomes. Such efforts will facilitate early diagnosis, improve treatment personalization, and ultimately enhance patient outcomes. Addressing these systemic issues is critical to ensuring equitable access to genetic services in India and fostering a more informed, proactive approach to breast cancer prevention and care.